Involvement of GABA Transporters in Atropine-treated Myopic Retina As Revealed by ITRAQ Quantitative Proteomics

Overview

Journal J Proteome Res

Publisher American Chemical Society

Specialty Biochemistry

Date 2014 Sep 12

PMID 25211393

Citations 38

Authors

Veluchamy A Barathi

Shyam S Chaurasia

Michael Poidinger

Siew Kwan Koh

Dechao Tian

Candice Ho

P Michael Iuvone

Roger W Beuerman

Lei Zhou

Affiliations

Soon will be listed here.

Abstract

Atropine, a muscarinic antagonist, is known to inhibit myopia progression in several animal models and humans. However, the mode of action is not established yet. In this study, we compared quantitative iTRAQ proteomic analysis in the retinas collected from control and lens-induced myopic (LIM) mouse eyes treated with atropine. The myopic group received a (-15D) spectacle lens over the right eye on postnatal day 10 with or without atropine eye drops starting on postnatal day 24. Axial length was measured by optical low coherence interferometry (OLCI), AC-Master, and refraction was measured by automated infrared photorefractor at postnatal 24, 38, and 52 days. Retinal tissue samples were pooled from six eyes for each group. The experiments were repeated twice, and technical replicates were also performed for liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis. MetaCore was used to perform protein profiling for pathway analysis. We identified a total of 3882 unique proteins with <1% FDR by analyzing the samples in replicates for two independent experiments. This is the largest number of mouse retina proteome reported to date. Thirty proteins were found to be up-regulated (ratio for myopia/control > global mean ratio + 1 standard deviation), and 28 proteins were down-regulated (ratio for myopia/control < global mean ratio - 1 standard deviation) in myopic eyes as compared with control retinas. Pathway analysis using MetaCore revealed regulation of γ-aminobutyric acid (GABA) levels in the myopic eyes. Detailed analysis of the quantitative proteomics data showed that the levels of GABA transporter 1 (GAT-1) were elevated in myopic retina and significantly reduced after atropine treatment. These results were further validated with immunohistochemistry and Western blot analysis. In conclusion, this study provides a comprehensive quantitative proteomic analysis of atropine-treated mouse retina and suggests the involvement of GABAergic signaling in the antimyopic effects of atropine in mouse eyes. The GABAergic transmission in the neural retina plays a pivotal role in the maintenance of axial eye growth in mammals.

Citing Articles

Evaluating the effect of 0.125% atropine on foveal microvasculature using optical coherence tomography angiography.

Tsai T, Huang Y, Yeung L, Chuang L, Chen H, Hwang Y Sci Rep. 2025; 15(1):5970.

PMID: 39966454 PMC: 11836047. DOI: 10.1038/s41598-025-88025-0.

Myopia in Children: Epidemiology, Genetics, and Emerging Therapies for Treatment and Prevention.

Surico P, Parmar U, Singh R, Farsi Y, Musa M, Maniaci A Children (Basel). 2025; 11(12.

PMID: 39767875 PMC: 11674392. DOI: 10.3390/children11121446.

Key role for inflammation-related signaling in the pathogenesis of myopia based on evidence from proteomics analysis.

Jiang L, Koh J, Seah S, Shan Dan Y, Wang Z, Chan X Sci Rep. 2024; 14(1):23486.

PMID: 39379387 PMC: 11461836. DOI: 10.1038/s41598-024-67337-7.

Lactylome analysis reveals potential target modified proteins in the retina of form-deprivation myopia.

Feng J, Chen X, Li R, Xie Y, Zhang X, Guo X iScience. 2024; 27(9):110606.

PMID: 39246443 PMC: 11379675. DOI: 10.1016/j.isci.2024.110606.

Insights into Myopia from Mouse Models.

Mazade R, Palumaa T, Pardue M Annu Rev Vis Sci. 2024; 10(1):213-238.

PMID: 38635876 PMC: 11615738. DOI: 10.1146/annurev-vision-102122-102059.

References

Gustincich S, Feigenspan A, Wu D, KOOPMAN L, Raviola E . Control of dopamine release in the retina: a transgenic approach to neural networks. Neuron. 1997; 18(5):723-36. DOI: 10.1016/s0896-6273(00)80313-x. View

Baba H, Kohno T, Okamoto M, Goldstein P, Shimoji K, Yoshimura M . Muscarinic facilitation of GABA release in substantia gelatinosa of the rat spinal dorsal horn. J Physiol. 1998; 508 ( Pt 1):83-93. PMC: 2230847. DOI: 10.1111/j.1469-7793.1998.083br.x. View

Saw S, Gazzard G, Au Eong K, Tan D . Myopia: attempts to arrest progression. Br J Ophthalmol. 2002; 86(11):1306-11. PMC: 1771373. DOI: 10.1136/bjo.86.11.1306. View

Mertz J, Wallman J . Choroidal retinoic acid synthesis: a possible mediator between refractive error and compensatory eye growth. Exp Eye Res. 2000; 70(4):519-27. DOI: 10.1006/exer.1999.0813. View

Tong L, Huang X, Koh A, Zhang X, Tan D, Chua W . Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine. Ophthalmology. 2009; 116(3):572-9. DOI: 10.1016/j.ophtha.2008.10.020. View

Ross P, Huang Y, Marchese J, Williamson B, Parker K, Hattan S . Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004; 3(12):1154-69. DOI: 10.1074/mcp.M400129-MCP200. View

Fischer A, Miethke P, Morgan I, Stell W . Cholinergic amacrine cells are not required for the progression and atropine-mediated suppression of form-deprivation myopia. Brain Res. 1998; 794(1):48-60. DOI: 10.1016/s0006-8993(98)00188-7. View

Cheng Z, Chebib M, Schmid K . Identification of GABA receptors in chick cornea. Mol Vis. 2012; 18:1107-14. PMC: 3351410. View

Stone R, Lin T, Laties A, Iuvone P . Retinal dopamine and form-deprivation myopia. Proc Natl Acad Sci U S A. 1989; 86(2):704-6. PMC: 286542. DOI: 10.1073/pnas.86.2.704. View

10.

Midelfart A, Kinge B, Midelfart S, Lydersen S . Prevalence of refractive errors in young and middle-aged adults in Norway. Acta Ophthalmol Scand. 2002; 80(5):501-5. DOI: 10.1034/j.1600-0420.2002.800508.x. View

11.

Akerman C, Cline H . Refining the roles of GABAergic signaling during neural circuit formation. Trends Neurosci. 2007; 30(8):382-9. DOI: 10.1016/j.tins.2007.06.002. View

12.

Buck C, Schaeffel F, Simon P, Feldkaemper M . Effects of positive and negative lens treatment on retinal and choroidal glucagon and glucagon receptor mRNA levels in the chicken. Invest Ophthalmol Vis Sci. 2004; 45(2):402-9. DOI: 10.1167/iovs.03-0789. View

13.

Chia A, Li W, Tan D, Luu C . Full-field electroretinogram findings in children in the atropine treatment for myopia (ATOM2) study. Doc Ophthalmol. 2013; 126(3):177-86. DOI: 10.1007/s10633-012-9372-8. View

14.

Lam T, Li K, Lo S, Guggenheim J, To C . Application of fluorescence difference gel electrophoresis technology in searching for protein biomarkers in chick myopia. J Proteome Res. 2007; 6(11):4135-49. DOI: 10.1021/pr0701097. View

15.

Gibbs M, Johnston G . Opposing roles for GABAA and GABAC receptors in short-term memory formation in young chicks. Neuroscience. 2005; 131(3):567-76. DOI: 10.1016/j.neuroscience.2004.11.033. View

16.

Ellis Jr G, Frey T, Gouterman R . Myelinated nerve fibers, axial myopia, and refractory amblyopia: an organic disease. J Pediatr Ophthalmol Strabismus. 1987; 24(3):111-9. DOI: 10.3928/0191-3913-19870501-04. View

17.

Cheng Z, Chebib M, Schmid K . ρ1 GABAC receptors are expressed in fibrous and cartilaginous layers of chick sclera and located on sclera fibroblasts and chondrocytes. J Neurochem. 2011; 118(2):281-7. DOI: 10.1111/j.1471-4159.2011.07300.x. View

18.

Stone R, Liu J, Sugimoto R, Capehart C, Zhu X, Pendrak K . GABA, experimental myopia, and ocular growth in chick. Invest Ophthalmol Vis Sci. 2003; 44(9):3933-46. DOI: 10.1167/iovs.02-0774. View

19.

Cooper J, Schulman E, Jamal N . Current status on the development and treatment of myopia. Optometry. 2012; 83(5):179-99. View

20.

Rohrer B, Spira A, Stell W . Apomorphine blocks form-deprivation myopia in chickens by a dopamine D2-receptor mechanism acting in retina or pigmented epithelium. Vis Neurosci. 1993; 10(3):447-53. DOI: 10.1017/s0952523800004673. View